POMDOCTOR Ltd
POM Nasdaq· Retail-Miscellaneous Retail
KIRA · Stoqly’s AI analyst, in plain words
- POMDOCTOR Ltd had $55.6M of revenue in fiscal 2025, up 16.9% on the year before.
- Its operating margin was −29.7%, down 22.1 pts: of every 100 in sales, about −30 is left after running the business.
- POMDOCTOR Ltd lost $18.2M in fiscal 2025.
- Free cash flow was −$20.8M in fiscal 2025, −37.4% of revenue.
- POMDOCTOR Ltd owes $17.9M more than it holds in cash.
Market cap
—
P/E
—
Revenue
$55.6M
Net income
−$18.2M
Free cash flow
−$20.8M
Operating margin
−29.7%
POMDOCTOR Ltd in 30 seconds · fiscal 2025
Are sales growing?
+16.9%
Yes. Sales grew 16.9% last year.
Does it make a profit?
−32.7%
No. It lost money last year.
Does profit turn into cash?
−37.4%
No. It spent more cash than it brought in.
How healthy are the accounts?
1 / 9
Weak. It passes 1 of 9 health tests.
What POMDOCTOR Ltd does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 20-F · May 14, 2026
- Legal name
- POMDOCTOR Ltd
- CIK
- 0001877971
POMDOCTOR Ltd · POM
Results and finances
The last 3 fiscal years. Amounts in USD.
| Fiscal year | FY23 | FY24 | FY25 |
|---|---|---|---|
| Sales and profit | |||
| Revenue | $43.0M | $47.6M | $55.6M |
| Revenue growth | — | 10.6% | 16.9% |
| Gross margin | 12.7% | 13.9% | 13.1% |
| Operating margin | −7.3% | −7.5% | −29.7% |
| Net income | −$5.2M | −$5.2M | −$18.2M |
| Net margin | −12.1% | −10.9% | −32.7% |
| Diluted EPS | −$3.25 | −$3.16 | −$3.06 |
| Cash | |||
| Cash from operations | −$6.5M | −$2.2M | −$20.7M |
| Capital expenditure | $0.0M | $0.0M | $0.1M |
| Free cash flow | −$6.5M | −$2.2M | −$20.8M |
| FCF margin | −15.1% | −4.7% | −37.4% |
| Share count change | — | 0.0% | 53.4% |
| Debt and strength | |||
| Cash and short-term investments | $0.9M | $1.0M | $1.4M |
| Debt incl. finance leases | — | $4.8M | $19.3M |
| Deposits | $0.9M | $1.0M | $1.3M |
| Shareholders' equity | −$298M | −$310M | −$64.8M |
| Current ratio | — | 0.2x | 0.5x |
| Interest coverage | −7.4x | −7.1x | −30.1x |
| Returns and quality | |||
| Piotroski F-score | — | — | 1 |
| Altman Z'' | — | −187.9 | −90.0 |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
POMDOCTOR Ltd · POM
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
Source: SEC EDGAR XBRL filings (CIK 0001877971). Data updated October 24, 2026. Filed in CNY under US GAAP and converted to US$: income and cash-flow lines at each period's average exchange rate, balance-sheet lines at the period-end rate. For information only — not investment advice. Check the original filings before relying on any figure.